233 related articles for article (PubMed ID: 24703976)
21. Commensals Serve as Natural Barriers to Mammalian Cells during Acanthamoeba castellanii Invasion.
Wang YJ; Chen CH; Chen JW; Lin WC
Microbiol Spectr; 2021 Dec; 9(3):e0051221. PubMed ID: 34935418
[TBL] [Abstract][Full Text] [Related]
22. Cellulose biosynthesis pathway is a potential target in the improved treatment of Acanthamoeba keratitis.
Dudley R; Alsam S; Khan NA
Appl Microbiol Biotechnol; 2007 May; 75(1):133-40. PubMed ID: 17225099
[TBL] [Abstract][Full Text] [Related]
23. Quantitative proteomic analysis and functional characterization of Acanthamoeba castellanii exosome-like vesicles.
Lin WC; Tsai CY; Huang JM; Wu SR; Chu LJ; Huang KY
Parasit Vectors; 2019 Oct; 12(1):467. PubMed ID: 31597577
[TBL] [Abstract][Full Text] [Related]
24. On the mechanism of oleate transport across human brain microvessel endothelial cells.
Mitchell RW; Edmundson CL; Miller DW; Hatch GM
J Neurochem; 2009 Aug; 110(3):1049-57. PubMed ID: 19493158
[TBL] [Abstract][Full Text] [Related]
25. Acanthamoeba castellanii Proteases are Capable of Degrading Iron-Binding Proteins as a Possible Mechanism of Pathogenicity.
Ramírez-Rico G; Martínez-Castillo M; de la Garza M; Shibayama M; Serrano-Luna J
J Eukaryot Microbiol; 2015; 62(5):614-22. PubMed ID: 25737266
[TBL] [Abstract][Full Text] [Related]
26. Metformin-coated silver nanoparticles exhibit anti-acanthamoebic activities against both trophozoite and cyst stages.
Anwar A; Soomaroo A; Anwar A; Siddiqui R; Khan NA
Exp Parasitol; 2020 Aug; 215():107915. PubMed ID: 32461112
[TBL] [Abstract][Full Text] [Related]
27. Antimicrobial action of biguanides on the viability of Acanthamoeba cysts and assessment of cell toxicity.
Mafra CS; Carrijo-Carvalho LC; Chudzinski-Tavassi AM; Taguchi FM; Foronda AS; Carvalho FR; de Freitas D
Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6363-72. PubMed ID: 23900604
[TBL] [Abstract][Full Text] [Related]
28. Failure of Acanthamoeba castellanii to produce intraocular infections.
Clarke DW; Alizadeh H; Niederkorn JY
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2472-8. PubMed ID: 15980238
[TBL] [Abstract][Full Text] [Related]
29. Characterization of novel extracellular proteases produced by Acanthamoeba castellanii after contact with human corneal epithelial cells and their relevance to pathogenesis.
Loufouma-Mbouaka A; Martín-Pérez T; Köhsler M; Danisman Z; Schwarz M; Mazumdar R; Samba-Louaka A; Walochnik J
Parasit Vectors; 2024 May; 17(1):242. PubMed ID: 38812022
[TBL] [Abstract][Full Text] [Related]
30. Phospholipase activities in clinical and environmental isolates of Acanthamoeba.
Matin A; Jung SY
Korean J Parasitol; 2011 Mar; 49(1):1-8. PubMed ID: 21461262
[TBL] [Abstract][Full Text] [Related]
31. Acanthamoeba interactions with human brain microvascular endothelial cells.
Alsam S; Kim KS; Stins M; Rivas AO; Sissons J; Khan NA
Microb Pathog; 2003 Dec; 35(6):235-41. PubMed ID: 14580387
[TBL] [Abstract][Full Text] [Related]
32. The effect of different environmental conditions on the encystation of Acanthamoeba castellanii belonging to the T4 genotype.
Aqeel Y; Siddiqui R; Iftikhar H; Khan NA
Exp Parasitol; 2013 Sep; 135(1):30-5. PubMed ID: 23769934
[TBL] [Abstract][Full Text] [Related]
33. Comparison of specific activity and cytopathic effects of purified 33 kDa serine proteinase from Acanthamoeba strains with different degree of virulence.
Kim WT; Kong HH; Ha YR; Hong YC; Jeong HJ; Yu HS; Chung DI
Korean J Parasitol; 2006 Dec; 44(4):321-30. PubMed ID: 17170574
[TBL] [Abstract][Full Text] [Related]
34. Characterization and pathogenetic role of proteinase from Acanthamoeba castellanii.
Na BK; Kim JC; Song CY
Microb Pathog; 2001 Jan; 30(1):39-48. PubMed ID: 11162184
[TBL] [Abstract][Full Text] [Related]
35. Clinical and histologic evaluations of experimental Acanthamoeba keratitis.
Polat ZA; Ozcelik S; Vural A; Yildiz E; Cetin A
Parasitol Res; 2007 Nov; 101(6):1621-5. PubMed ID: 17701053
[TBL] [Abstract][Full Text] [Related]
36. Acanthamoeba castellanii: morphological analysis of the interaction with human cornea.
Omaña-Molina M; González-Robles A; Salazar-Villatoro LI; Cristóbal-Ramos AR; González-Lázaro M; Salinas-Moreno E; Méndez-Cruz R; Sánchez-Cornejo M; De la Torre-González E; Martínez-Palomo A
Exp Parasitol; 2010 Sep; 126(1):73-8. PubMed ID: 20146924
[TBL] [Abstract][Full Text] [Related]
37. Effect of non-steroidal anti-inflammatory drugs on biological properties of Acanthamoeba castellanii belonging to the T4 genotype.
Siddiqui R; Lakhundi S; Iqbal J; Khan NA
Exp Parasitol; 2016 Sep; 168():45-50. PubMed ID: 27381503
[TBL] [Abstract][Full Text] [Related]
38. Protease activated receptor signaling is required for African trypanosome traversal of human brain microvascular endothelial cells.
Grab DJ; Garcia-Garcia JC; Nikolskaia OV; Kim YV; Brown A; Pardo CA; Zhang Y; Becker KG; Wilson BA; de A Lima AP; Scharfstein J; Dumler JS
PLoS Negl Trop Dis; 2009 Jul; 3(7):e479. PubMed ID: 19621073
[TBL] [Abstract][Full Text] [Related]
39. Cytotoxic activity and degradation patterns of structural proteins by corneal isolates of Acanthamoeba spp.
Sant'ana VP; Carrijo-Carvalho LC; Foronda AS; Chudzinski-Tavassi AM; de Freitas D; de Carvalho FR
Graefes Arch Clin Exp Ophthalmol; 2015 Jan; 253(1):65-75. PubMed ID: 25161076
[TBL] [Abstract][Full Text] [Related]
40. Cytopathic Change and Inflammatory Response of Human Corneal Epithelial Cells Induced by Acanthamoeba castellanii Trophozoites and Cysts.
Sohn HJ; Seo GE; Lee JH; Ham AJ; Oh YH; Kang H; Shin HJ
Korean J Parasitol; 2019 Jun; 57(3):217-223. PubMed ID: 31284343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
